After several days of DD I believe is ripe for a takeover before and of its products get approved due to the current cheap PPS. Current valuation for a buyout within the next 6 months 20.00 After Q2 look for a buyout in the 30.00 range. I believe AMGN might be the suitor, due to past asthma drug failures, this might be their next ticket to increase their pipeline which is getting old
There is no reason for ARRY to look favorably on an AMGN buyout. They are independent & they are successful. Ron Squarer isn't part of the old AMGN bunch. Years ago AMGN wanted to move this facility from Boulder. These guys said no. Started ARRY. It got some traction. The old CEO left due to a family issue if I recall correctly. They then hired Ron to be CEO.
ARRY is hitting on all cylinder. If they play this correctly we will have a multibillion market cap and then we can buy AMGN.
Quit wishing for a buyout. If you have been here as long as I have you want to follow a REGN type of story.